Education
About Us
Working with TipRanks
Follow Us
Mark Collingbourne Insider Profile
4 Followers
Mark Collingbourne, Director at Sosandar PLC, holds 91.09K shares in Probiotix Health Plc (Ticker: GB:PBX), holds 2.67M shares in Sosandar PLC (Ticker: GB:SOS). Most recently, Mark Collingbourne Bought ― shares of Probiotix Health Plc on Nov 05, 2024 for an estimated value of 4.40K.
Mark Collingbourne has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Collingbourne holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Collingbourne
Mark Collingbourne's Trading History
Sosandar PLC
Apr 10, 2017
Director
Informative Buy
40.00K
£160.00K
Probiotix Health Plc
Nov 05, 2024
Company Secretary
Informative Buy
4.40K
―
List of latest transactions for each holding click on a transaction to see Mark Collingbourne's performance on stock
You May Also Like
Mark Collingbourne insider profile FAQ
What is the percentage of profitable transactions made by Mark Collingbourne?
The percentage of profitable transactions made by Mark Collingbourne is ―.
What is the average return per transaction made by Mark Collingbourne?
The average return per transaction made by Mark Collingbourne is ―.
What stocks does Mark Collingbourne hold?
Mark Collingbourne holds: GB:SOS, GB:PBX stocks.
What was Mark Collingbourne’s latest transaction?
Mark Collingbourne latest transaction was an Informative Buy of 4.40K.
What was Mark Collingbourne's most profitable transaction?
Mark Collingbourne’s most profitable transaction was an Informative Buy of GB:SOS stock on April 10, 2017. The return on the trade was -43.20%.
What is Mark Collingbourne's role in Sosandar PLC?
Mark Collingbourne's role in Sosandar PLC is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.